SVROF yields 2272.73% · JNJ yields 2.13%● Live data
📍 SVROF pulled ahead of the other in Year 1
Combined, SVROF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SVROF + JNJ for your $10,000?
Silver Predator Corp., an exploration stage company, engages in the exploration and development of resource properties in the United States. It primarily explores for gold, silver, and copper deposits. The company owns interests in the Copper King/Sonora silver property, which consists of 50 unpatented lode claims located in Shoshone County, Idaho; and Taylor silver-gold project comprising 131 unpatented lode claims, 4 patented lode claims, and 5 unpatented mill site claims located in White Pine County, Nevada. It also holds interest in the Cordero property, which include 52 unpatented lode mining claims located in Humboldt County, Nevada; and Cornucopia property that comprises 1 patented and 28 unpatented lode claims located in Elko County, Nevada. The company was formerly known as Platoro West Holdings Inc. and changed its name to Silver Predator Corp. in June 2010. The company was incorporated in 2006 and is headquartered in Vancouver, Canada. Silver Predator Corp. is a subsidiary of Till Capital Corporation.
Full SVROF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.